Skip to content

Efficacy of Adding Intrathecal Morphine to Erector Spinae Plane Block for Postoperative Analgesia After Midline Laparotomy

Efficacy of Adding Intrathecal Morphine to Erector Spinae Plane Block for Postoperative Analgesia After Midline Laparotomy: A Prospective Randomized Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07720739
Enrollment
75
Registered
2026-07-22
Start date
2026-07-01
Completion date
2026-12-01
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Midline Laparotomy, Postoperative Pain

Keywords

Erector Spinae Plane Block, Intrathecal morphine, Opioid-sparing, Abdominal surgery

Brief summary

This study evaluates whether combining two distinct pain-relief techniques-a peripheral nerve block called the Erector Spinae Plane Block (ESPB) and a low-dose spinal medication injection called Intrathecal Morphine (ITM)-provides better postoperative pain management for adult patients undergoing major midline abdominal surgery (laparotomy) compared to using either technique alone. The main goal is to see if this combination improves pain control and reduces the total amount of opioids required by patients within the first 48 hours after surgery.

Interventions

DRUGIntrathecal Morphine

Administration of a single-shot intrathecal injection containing hyperbaric bupivacaine combined with preservative-free morphine (ITM) during spinal anesthesia prior to the surgical incision."

PROCEDUREErector Spinae Plane Block

Bilateral ultrasound-guided erector spinae plane block performed at the T8-T10 level using a local anesthetic solution (such as bupivacaine or ropivacaine) injected deep to the erector spinae muscle fascia for postoperative abdominal analgesia.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Patients scheduled to undergo elective or emergency midline exploratory laparotomy. American Society of Anesthesiologists (ASA) physical status I, II, or III. Intact cognitive ability to comprehend study procedures, use the Numeric Rating Scale (NRS) accurately, and provide informed consent.

Exclusion criteria

Contraindications to regional or neuraxial anesthesia (e.g., patient refusal, localized infection at needle insertion sites, known coagulopathy (INR \>1.5 or platelet count \<80,000/\\mu L), or un-pausable therapeutic anticoagulation). Known allergy or severe hypersensitivity to local anesthetics or morphine. Chronic pain conditions requiring daily opioid consumption for \>3 months preoperatively. Documented history of substance use disorder. Severe chronic respiratory disease (e.g., COPD requiring home oxygen therapy, or severe obstructive sleep apnea not managed with CPAP). Neurological or psychiatric conditions that compromise sensory perception or communication. Surgical incisions planned to extend significantly past the midline. Severe spinal deformities or a history of spinal surgery at the targeted block/injection interspaces. Concurrent enrollment in any other interventional clinical trial.

Design outcomes

Primary

MeasureTime frameDescription
Time to First Rescue AnalgesiaUp to 48 hours postoperatively.Duration of time (in minutes/hours) elapsed from PACU admission to the patient's first request for an IV morphine rescue bolus.
Postoperative Pain IntensityAt rest and during a standardized cough at 0, 2, 4, 6, 12, 24, and 48 hours postoperatively.Numeric Rating Scale (NRS) score ranging from 0 (no pain) to 10 (worst imaginable pain).
Cumulative Opioid ConsumptionUp to 48 hours postoperatively.Total postoperative intravenous rescue morphine consumed, calculated and recorded in Morphine Milligram Equivalents (MME).

Secondary

MeasureTime frameDescription
Time to First AmbulationUp to hospital discharge (typically up to 7 days).Time taken (in hours) from the end of surgery until the patient is able to walk more than 5 meters with assistance.
Time to Readiness for PACU DischargeWithin the first 24 hours postoperatively.Time in minutes from PACU admission until the patient achieves a modified Aldrete score \\ge9.
Incidence of Adverse EventsUp to 48 hours postoperatively.Presence or absence (percentages) of respiratory depression (RR \<8/min or SpO\_2 \<90% on room air), PONV requiring treatment, or pruritus requiring treatment.
Patient Satisfaction with Pain ManagementAssessed at 48 hours postoperatively.Score on a 5-point Likert scale ranging from 1 (Dissatisfied) to 5 (Very Satisfied).
Quality of RecoveryPostoperative Day 1 (approximately 24 hours).Total score obtained from the 9-item Quality of Recovery (QoR-9) questionnaire.
Healthcare UtilizationFrom day of surgery to hospital discharge (up to 30 days).Total length of hospital stay measured in days.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026